» Articles » PMID: 15491358

Intestinal Barrier Dysfunction by Enteropathogenic Escherichia Coli is Mediated by Two Effector Molecules and a Bacterial Surface Protein

Overview
Journal Mol Microbiol
Date 2004 Oct 20
PMID 15491358
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

The human intestinal pathogen, enteropathogenic Escherichia coli (EPEC), causes diarrhoeal disease by a mechanism that is dependent on the injection of effector proteins into the host cell. One effector, EspF, is reported to be required for EPEC to disrupt tight junction integrity of intestinal cells and increase the paracellular movement of molecules, which is likely to contribute to diarrhoea. Here, we show that not one but three EPEC-encoded factors play important roles in this process. Thus, the Map (Mitochondria-associated protein) effector is shown to: (i) be as essential as EspF for disrupting intestinal barrier function, (ii) be able to function independently of EspF, (iii) alter tight junction structure and (iv) mediate these effects in the absence of mitochondrial targeting. Additionally, the outer membrane protein Intimin is shown to be crucial for EspF and Map to disrupt the intestinal barrier function. This function of Intimin is completely independent of its interaction with its known receptor Tir, revealing a physiologically relevant requirement for Intimin interaction with alternative receptor(s). This work demonstrates that EPEC uses multiple multifunctional proteins to elicit specific responses in intestinal cells and that EPEC can control the activity of its injected effector molecules from its extracellular location.

Citing Articles

Enteropathogenic E. coli effector Map interacts with Rab13 and regulates the depletion of the tight junction proteins occludin and claudins via cathepsin B-mediated mechanisms.

Mandal A, Walling P, Qureshi S, Kansal K, Aijaz S Biol Open. 2025; 14(2).

PMID: 39912222 PMC: 11892358. DOI: 10.1242/bio.061794.


Bacterial attachment and junctional transport function in induced apical-out polarized and differentiated canine intestinal organoids.

Yoshida S, Nakazawa M, Kawasaki M, Ambrosini Y Front Vet Sci. 2025; 11:1483421.

PMID: 39744718 PMC: 11688377. DOI: 10.3389/fvets.2024.1483421.


The C-terminal proline-rich repeats of Enteropathogenic E. coli effector EspF are sufficient for the depletion of tight junction membrane proteins and interactions with early and recycling endosomes.

Ansari I, Mandal A, Kansal K, Walling P, Khan S, Aijaz S Gut Pathog. 2024; 16(1):36.

PMID: 38972985 PMC: 11229284. DOI: 10.1186/s13099-024-00626-8.


Tissue-resident bacteria in metabolic diseases: emerging evidence and challenges.

Massier L, Musat N, Stumvoll M, Tremaroli V, Chakaroun R, Kovacs P Nat Metab. 2024; 6(7):1209-1224.

PMID: 38898236 DOI: 10.1038/s42255-024-01065-0.


Pathophysiology of Enteropathogenic -induced Diarrhea.

Kaur P, Dudeja P Newborn (Clarksville). 2023; 2(1):102-113.

PMID: 37388762 PMC: 10308259. DOI: 10.5005/jp-journals-11002-0056.